The North America medical second opinion market is expected to reach US$ 4,476.22 million by 2027 from US$ 1,480.14 million in 2020; it is estimated to grow at a CAGR of 17.1% from 2020 to 2027.
The market's growth is attributed to growing emphasis on superior treatment outcomes and increasing preference for healthcare cost optimization. However, the absence of clear-cut guidelines on using medical second opinion globally is likely to impact North America Medical Second Opinion market growth during the forecast period negatively.
Increasing emphasis on achieving better treatment outcomes drives the second medical opinion market. There is a high possibility of the adverse effects of many treatment procedures, which might also lead to mortality. Hence, it becomes essential to revise the current treatment alternatives in crucial cases and get advice from another reliable healthcare professional to avoid possible ill effects. According to a study published by the John Hopkins University in 2018, around 250,000 deaths are caused due to medical errors in the US each year. Such a large extent of medical errors is anticipated to encourage consumers to opt for a medical second opinion. According to the World Health Organization data, in 2018, an estimated 9.6 million patients across the globe lost their lives due to the occurrence of cancer. In addition, the growing exposure to risk factors such as consumption of tobacco, excessive alcoholism, unhealthy diet, and obesity is further projected to elevate the prevalence of cancer. Thus, an increasing prevalence of cancer, combined with a greater number of cancer patients seeking a second opinion, would be one of the prominent factors driving the medical second opinion market during the forecast period. Increasing healthcare-associated costs due to the overall shortage of healthcare professionals and limited availability of resources are generating the need for healthcare cost optimization worldwide. Also, growing emphasis on reducing additional costs and increasing awareness about the possible exploitation from healthcare organizations, especially in low- and middle-income countries, significantly drive the medical second medical opinion market.
The COVID-19 pandemic has severely affected the countries in the North American region. The second opinion for COVID-19 becomes a must in the region as the virus outbreak is continuously growing. Most countries in the region face complete lockdown; in this challenging time, the patient should be aware of the treatment options. For instance, Mount Sinai Health System is harnessing the power of artificial intelligence to help analyze lung scans in patients situated in the US for COVID-19. The high sensitivity of their AI model can provide a second opinion to physicians in cases where CT is either negative (in the early course of infection) or shows nonspecific findings, which can be common. Moreover, the government in the region asked for a second opinion on the usage of hydroxychloroquine as the effective treatment for COVID-19. Thus, it is likely that the outbreak of COVID-19 will support the growth of the medical second opinion market.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA MEDICAL SECOND OPINION MARKET SEGMENTATION
By Disorder
- Cancer
- Orthopaedic Disorders
- Cardiac Disorders
- Neurological Disorders
- Nephrological Disorders
- Hematologic Blood Disorders
- COPD (Chronic Obstructive Pulmonary Disease)
- Organ Transplant
- Other Diseases
By Service Provider
- Hospitals
- Health Insurance Companies
- Online Services
By Country
- US
- Canada
- Mexico
Company Profiles
- Second Opinion International
- Cigna
- WorldCare
- Medix
- 2nd.MD (Innovation Specialists LLC)
- AXA
North America Medical Second Opinion Report Scope
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 1,480.14 Million |
Market Size by 2027 | US$ 4,476.22 Million |
Global CAGR (2020 - 2027) | 17.1% |
Historical Data | 2018-2019 |
Forecast period | 2021-2027 |
Segments Covered |
By Disorders
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Second Opinion International
- Cigna
- WorldCare
- Medix
- 2nd.MD (Innovation Specialists LLC)
- AXA


